Picard Medical, Inc. Selling, General and Administrative Expense
Picard Medical, Inc. (PMI) reported Selling, General and Administrative Expense of $3.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-19
- Picard Medical, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $3.87M, a 46.02% increase year-over-year.
- Picard Medical, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.89M, a 38.99% increase year-over-year.
- Picard Medical, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $2.87M, a 1.78% decline year-over-year.
- Picard Medical, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.41M, a 14.38% decline year-over-year.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.87M 10-Q · filed 2026-08-19 | $6.76M 10-Q · filed 2026-08-19 | $9.63M derived: sum of 3 quarters · filed 2026-08-19 | $12.04M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $2.89M 10-Q · filed 2026-05-15 | $5.76M derived: sum of 2 quarters · filed 2026-05-15 | $8.16M derived: sum of 3 quarters · filed 2026-05-15 | $10.81M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $2.87M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $5.27M derived: sum of 2 quarters · filed 2026-05-01 | $7.92M derived: sum of 3 quarters · filed 2026-08-19 | $10.00M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $2.41M 10-Q · filed 2025-11-14 | $5.06M derived: sum of 2 quarters · filed 2026-08-19 | $7.14M 10-Q · filed 2025-11-14 | $10.06M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $2.65M 10-Q · filed 2026-08-19 | $4.73M 10-Q · filed 2026-08-19 | $7.65M derived: sum of 3 quarters · filed 2026-08-19 | $10.46M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $2.08M 10-Q · filed 2026-05-15 | $5.00M derived: sum of 2 quarters · filed 2026-05-15 | $7.81M derived: sum of 3 quarters · filed 2026-05-15 | $10.31M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $2.92M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $5.73M derived: sum of 2 quarters · filed 2026-05-01 | $8.23M derived: sum of 3 quarters · filed 2026-05-01 | $10.22M S-1/A · filed 2026-05-01 |
| 2024-09-30 | $2.81M 10-Q · filed 2025-11-14 | $5.31M derived: sum of 2 quarters · filed 2025-11-14 | $7.30M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $2.50M 10-Q · filed 2025-09-12 | $4.49M 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |